Viewing Study NCT03701295


Ignite Creation Date: 2025-12-24 @ 1:58 PM
Ignite Modification Date: 2026-02-13 @ 10:39 AM
Study NCT ID: NCT03701295
Status: COMPLETED
Last Update Posted: 2023-10-18
First Post: 2018-10-08
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Pinometostat and Azacitidine in Treating Patients With Relapsed, Refractory, or Newly Diagnosed Acute Myeloid Leukemia With 11q23 Rearrangement
Sponsor: National Cancer Institute (NCI)
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Acute Myeloid Leukemia With t(9;11)(p21.3;q23.3); MLLT3-MLL View
None Leukemia Cutis View
None Recurrent Acute Myeloid Leukemia View
None Refractory Acute Myeloid Leukemia View
Keywords: